✥ Click and hold to pan the map; scroll wheel and trackpad work too.
Volume. ClinicalTrials.gov API v2: interventional studies matching the condition and intervention terms. PubMed E-utilities: title/abstract matches, all records, filtered to randomized controlled trial[pt], and to systematic review[pt] OR meta-analysis[pt]. Open a cell to reach the exact live query.
Trending. Publication momentum uses relative growth rate, CAGR and doubling time (standard scientometric growth indicators), comparing 2020–22 with 2023–25 and normalising to growth of all of PubMed (+4%). Trial momentum compares interventional trial starts in the same windows against all ClinicalTrials.gov starts (+13%). ▲ Trending = publications growing ≥1.25× faster than PubMed (≥10 recent records) or trial starts ≥1.5× faster than the registry (≥5 recent trials). ★ Promising = regulatory or guideline signals of expected benefit since 2024 (FDA Breakthrough designation, new FDA/CE labels, G-BA finding of "Potenzial", guideline upgrades) or a recent positive meta-analysis. ✕ marks recent negative pivotal trials or guideline recommendations against. The score is a screening aid, not an efficacy estimate.
Certainty. Graded per cell from the IFCN rTMS guideline (Lefaucheur 2020), the tDCS guidelines (Lefaucheur 2017; Fregni 2021), Cochrane reviews and the most recent meta-analyses found. Where a GRADE rating was published it is used; otherwise the rating is an indicative judgement from the synthesis literature.